The largest database of trusted experimental protocols

17 protocols using 2 ag d8

1

Preparation of Cannabinoid Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lactic acid was purchased from Sigma Chemical Co. (St. Louis, MO, USA). AEA, AEA-d8, 2-AG, and 2-AG-d8 were purchased from Cayman Chemical (Ann Arbor, MI, USA). URB597 (cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester) (Fegley et al., 2005 (link)), rimonabant, and SR144528 (N-{(1S)-endo-1,3,3-trimethyl bicyclo[2.2.1] heptan-2yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide) (Griffin et al., 1999 (link)) were provided by the National Institute on Drug Abuse Drug Supply Program (Bethesda, MD, USA). Lactic acid was prepared in sterile water. URB597 was prepared in a vehicle consisting of 1% carboxymethylcellulose (Sigma), 1% Tween 80 (Sigma), 2% dimethyl sulfoxide (Sigma), and 96% sterile saline. rimonabant and SR144528 were prepared in a vehicle consisting of 5% ethanol, 5% cremophor (Sigma), and 90% sterile saline. All solutions were injected i.p. in a volume of 1 ml/kg except for URB597, which was injected i.p. in a volume of 2 ml/kg.
+ Open protocol
+ Expand
2

Lipid Extraction and Quantification from Mouse Brain and Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipids were extracted from mouse brain or serum essentially as described in (Wang et al. 2003 (link)) with the following modifications: Frozen mouse brain (100–200 mg tissue) was homogenized in 1.0 mL of ice-cold homogenization buffer containing 2000 pg each of the following deuterated standards (AEA-d4, OEA-d2, PEA-d4, DHEA-d4, EPEA-d4, and 2-AG-d8; Cayman Chemical, Ann Arbor, MI). Similar amounts of the respective deuterated standards were added to an aliquot (50 μL) of the serum prior to lipid extraction as described above. The final lipid residue was reconstituted in 100 μL of ice-cold methanol, purged with nitrogen, and stored at −80°C until analysis by liquid chromatography-mass spectrometry (LC-MS).
+ Open protocol
+ Expand
3

Quantification of Endocannabinoids and Lipid Mediators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Radioactive arachidonoyl ethanolamide[1-3H] ([3H]-AEA) was obtained from American Radiolabeled Chemicals, Inc (St Louis, MO, USA). (R)(-)-Flurbiprofen and (S)(+)-Flurbiprofen were purchased from Santa Cruz Biotechnology Inc. (Dallas, Texas, USA). Ovine COX-1 (cat. no. 60100), human recombinant COX-2 (cat. no. 60122), COX-2 polyclonal antibody (rabbit anti-mouse, cat #: 160106), arachidonic acid, 2-AG, AEA and URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) were purchased from the Cayman Chemical Co. (Ann Arbor, MI, USA). Substrates were dissolved in ethanol or DMSO as appropriate. Polyclonal goat anti-rabbit immunoglobulin/HRP was obtained from Dako (Glostrup, Denmark). Protease inhibitor cocktail set III was obtained from Merck Millipore (Darmstadt, Germany). For the lipid quantification experiments, the following native and deuterated standards were purchased from the Cayman Chemical Co.: AEA, 2-AG, PEA, OEA, DEA, LEA, SEA, 2-LG, AEA-d8, 2-AG-d8, PEA-d4, SEA-d3, OEA-d4, PGF, PGE2, TXB2, PGD2, 12(13)-EpOME, 9(10)-DiHOME, 12(13)-DiHOME, 11-HETE, 12-HETE, 15-HETE, 9-HODE, 13-HODE, 12-HEPE, 12-[[(cyclohexylamino)carbonyl]amino]-dodecanoic acid (CUDA), 12(13)-DiHOME-d4, 12(13)-EpOME-d4, 9-HODE-d4, PGE2-d4 and PGD2-d4. 9,10,13-TriHOME and 9,12,13-TriHOME were obtained from Larodan (Sweden, Malmö). For list of lipid abbreviations, see S1 Table.
+ Open protocol
+ Expand
4

Quantifying Endocannabinoid Signaling Molecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s modified Eagle’s medium, foetal calf serum and penicillin/streptomycin were from Corning (Corning, NY, USA). Bovine serum albumin (BSA) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Sphingosine-1-phosphate (S1P, cod.62570) and methanandamide (N-(2-hydroxy-1R-methylethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide, cod.157182-49-5) were from Cayman Chemicals (Ann Arbor, MI, USA); N-arachidonoyl-ethanolamine (anandamide (AEA), cod. A0580) and 2-arachidonoil-glycerol (2-AG, cod. A8973) were from Sigma-Aldrich (St. Louis, MO, USA). AEA-d8 and 2-AG-d8 were purchased from Cayman Chemicals (Ann Arbor, MI, USA) and were used as internal standards. The selective antagonists of CB1 SR141716A (SR1, cod. SML0800), of CB2 SR144528 (SR2, cod. SML1899) and of GPR55 ML193 trifluoroacetate (ML193, cod. SML1340) were from Sigma-Aldrich (St. Louis, MO, USA). The TRPV1 selective antagonist 5′-iodoresiniferatoxin (I-RTX, cod. 1362) was from TOCRIS (Bristol, UK). For molecular biology studies RevertAid H Minus First Strand cDNA Synthesis Kit, from Thermo Scientific (Waltham, MA, USA), and SensiFASTTM SYBR Lo-ROX kit, from Bioline (London, UK) were used.
+ Open protocol
+ Expand
5

Quantitative Lipid Profiling of Mouse Liver

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipids were extracted from mouse livers as described earlier [11 (link), 28 ]. Briefly, frozen mouse liver (100–200 mg wet weight) was homogenized in 1.0 mL of ice-cold homogenization buffer containing each of the deuterated standards AEA-d4, OEA-d2, PEA-d4, DHEA-d4, EPEA-d4, and 2-AG-d8 such that the final amount of each standard was 2000pg. The final lipid residue was redissolved in 100 μL of ice-cold methanol, purged with N2, and stored at −80°C until liquid chromatography-mass spectrometry (LC-MS) analysis below.
LC/MS analysis of liver NAE and 2-MG was performed as described earlier by our lab [30 (link), 31 (link)]. Briefly, identification and quantitation of individual NAE or 2-MG was accomplished through use of: i) Addition of internal standards to each aliquot of liver homogenate including deuterated AEA-d4, OEA-d2, PEA-d4, DHEA-d4, EPEA-d4, and 2-AG-d8 from Cayman Chemical (Ann Arbor, MI); ii) Comparison with external standard curves of n-6 arachidonoylethanolamide (AEA), oleoylethanolamide (OEA), palmitoylethanolamide (PEA), n-3 docosahexaenoylethanolamide (DHEA), n-3 eicosapentaenoylethanolamide (EPEA), 2-arachidonoylglycerol (2-AG), 2-oleoylglycerol (2-OG), and 2-palmitoylglycerol (2-PG) from Cayman Chemical (Ann Arbor, MI). All reagents and solvents used for extraction and LC/MS were of the highest commercial grade available.
+ Open protocol
+ Expand
6

Lipid Extraction from Skin Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Skin samples were thawed at 4 °C in ice. After weighing, 500 µL of phosphate buffer 0.1 mM pH 5.6 and 2 µL ISTD spiking solution containing AEA-d8, PEA-d4, OEA-d2 and 2AG-d8 (Cayman Chemical) were added to all samples. Chloroform:MeOH (2:1) 500 µL was added, and the samples were then vortexed vigorously for 2 cycles of 5 s at 5,000 rpm using a bead beater and centrifuged at 20,000 × g for 10 min at 4 °C, after which the organic layer was removed. This procedure was repeated three times, and all the organic phases were pooled. Then, the organic phase was evaporated in a CentriVap concentrator at 50 °C until dryness and reconstituted in 100 µL of acetonitrile. The supernatant was then transferred to HPLC vials to be injected (5 µL) into an LC–MS/MS device.
+ Open protocol
+ Expand
7

Quantification of Endocannabinoid Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unlabeled AEA (n-6 arachidonoylethanolamide), OEA (oleoylethanolamide), PEA (palmitoylethanolamide), DHEA (n-3 docosahexaenoylethanolamide), EPEA (n-3 eicosapentaenoylethanolamide), 2-AG (2-arachidonoylglycerol), 2-OG (2-oleoylglycerol), and 2-PG (2-palmitoylglycerol) were purchased from Cayman Chemical (Ann Arbor, MI). Deuterated AEA-d4, OEA-d2, PEA-d4, DHEA-d4, EPEA-d4, and 2-AG-d8 were also from Cayman Chemical (Ann Arbor, MI).
+ Open protocol
+ Expand
8

Inhibition of ABHD6 and ABPP Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
KT182, an ABHD6 inhibitor, and HT-01, the activity-based protein profiling (ABPP) probe specific for ABHD6, were kindly provided by Drs. Hsu and Cravatt [26 (link)]. 2-Arachidonoylglycerol [glycerol-1,2,3-3H] was from American Radiolabeled Chemicals Inc. (Saint Louis, MO). Cyclooxygenase inhibitor assay kits including COX inhibitor and recombinant COX-1 or COX-2 activity assay kit were from Cayman Chemical (Ann Arbor, MI). siRNA (FlexiTube Mm_abhd6_3 and Allstars Negative Control) and HiPerfect transfection reagent were from QIAGEN (Valencia, CA). WWL70, methyl arachidonyl fluorophosphonate (MAFP), SR141716 (SR1), SR144528 (SR2), 2-AG, 2-AG-d8, and AA were purchased from Cayman Chemical. Other reagents including lipopolysaccharide (LPS) were purchased from Sigma-Aldrich (St. Louis, MO).
+ Open protocol
+ Expand
9

Quantitative Lipid Profiling Methodology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified unlabeled N-acylethanolamides (NAEs) and 2-monoacylglycerols (2-MGs) as well as their deuterated analogues were from Cayman Chemical (Ann Arbor, MI) as follows: n-6 arachidonoylethanolamine (AEA), oleoylethanolamide (OEA), palmitoylethanolamide (PEA), n-3 docosahexaenoylethanolamide (DHEA), n-3 eicosapentaenoylethanolamide (EPEA), 2-arachidonoylglycerol (2-AG), 2-oleoylglycerol (2-OG), 2-palmitoylglycerol (2-PG), AEA-d4, OEA-d2, PEA-d4, DHEA-d4, EPEA-d4, 2-AG-d8, and arachidonic acid-d8 (ARA-d8, 20:4n-6-d8. Cis-parinaric acid was from Invitrogen (Grand Island, NY, USA). All reagents and solvents were the highest grade commercially available.
+ Open protocol
+ Expand
10

Diacylglycerol Lipase Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
10 μL DAG (10 mg/ml in CH3CN) was mixed with 50 μL Lyso phosphatidyl choline (LPC-SIGMA at 5 mg/ml in CHCL3), evaporated to dryness, solubilized with 30 μL CHCI3 followed by 100 μL of homogenizing buffer (0.1 M MOPS pH 7.4, 0, 25% BSA) and then subjected to ultrasound using a warming ultrasonic bath (Deltasonic) in an open tube for 15 min at 37°C, allowing slow CHCL3 evaporation and liposome generation.
DAGL activity. was measured at 37°C for 20 hours with 90 μL of 100 mM MOPS pH 7.4, 100 μL of purified fraction from brain, or equivalent quantity of recombinant ABHD11, and 10 μL DAG in LPC liposome as substrate (150 μΜ final DAG) or variable amount for enzymatic characterization.
For PMSF and RHC80267 inhibition, preincubation was carried out for 30 min at 3 mM and 1 mM, respectively, before adding DAG. RHC80267 (Sigma Aldrich) was also used. The reactions were stopped by adding chloroform supplemented with internal standard 2-AG-D8 (Cayman chemicals) for extraction. After centrifugation (5 min at 1500g), the organic layers were collected and dried under vacuum. The residues were suspended with 50 μL of H20/CH3CN mix (80:20) and analyzed by high performance liquid chromatography/mass spectrometry in "MRM-like" mode.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!